Skip to main content

Adenovirus-mediated myocardial gene therapy

  • Chapter
Molecular Approaches to Heart Failure Therapy
  • 92 Accesses

Abstract

The introduction of genetic material to the heart showed promise when adenovirus vectors were demonstrated to easily and efficiently transfer reporter genes to isolated cardiac myocytes in vitro [17, 18]. Numerous possibilities for the new technology were readily apparent. The most obvious was the replacement of genetic defects in inherited disorders, such as the long QT syndrome and several types of hypertrophic and dilated cardiomyopathies. Even more exciting, however, was the prospect of using this technology to modify more common, acquired diseases including ischemic diseases, acquired cardiomyopathies and arrhythmias. Most of these diseases affect every cell in the heart, so therapeutic applications would require delivery of the gene of interest to a majority of the myocytes in a homogeneous pattern throughout the heart.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM, Leiden JM (1994) Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Therapy 1:51–58

    PubMed  CAS  Google Scholar 

  2. Bergelson JM, Cunningham JA, Droguett G, Kurtjones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323

    Article  PubMed  CAS  Google Scholar 

  3. Breil I, Koch T, Belz M, Vanackern K, Neuhof H (1997) Effects of bradykinin, histamine, and serotonin on pulmonary vascular resistance and permeability. Acta Physiologica Scandinavica 159:189–198

    Article  PubMed  CAS  Google Scholar 

  4. Chapman RA (1987) Calcium channels, the sodium-calcium exchange and intracellular sodium in the predisposition of the heart to the calcium paradox. Biomed Biochem Acta 46:S512–S516

    CAS  Google Scholar 

  5. Chardonnet Y, Dales S (1970) Early events in the interaction of adenoviruses with HeLa cells: I. penetration of type 5 and intracellular release of the DNA genome. Virology 40:462–477

    Article  PubMed  CAS  Google Scholar 

  6. Chen HH, Mack LM, Kelly R, Ontell M, Kochanek S, Clemens PR (1997) Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc Natl Acad Sci USA 94:1645–1650

    Article  PubMed  CAS  Google Scholar 

  7. Chroboczek J, Bieber F, Jacrot B (1992) The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280–285

    Article  PubMed  CAS  Google Scholar 

  8. de Roos WK, Fallaux FJ, Marinelli AW, Lazaris-Karatzas A, von Geusau AB, van der Eb MM, Cramer SJ, Terpstra OT, Hoeben RC (1997) Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. Gene Ther 4:55–62

    Article  PubMed  Google Scholar 

  9. Donahue JK, Kikkawa K, Johns DC, Marban E, Lawrence JH (1997) Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci USA 94:4664–4668

    Article  PubMed  CAS  Google Scholar 

  10. Fechner H, Haack A, Wang H, Wang X, Eizema K, Pauschinger M, Schoemaker R, Veghel R, Houtsmuller A, Schultheiss HP, Lamers J, Poller W (1999) Expression of Coxsackie adenovirus receptor and alpha-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Therapy 6:1520–1535

    Article  PubMed  CAS  Google Scholar 

  11. Ghosh-Choudhury G, Haj-Ahmad Y, Graham FL (1987) Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J 6:1733–1739

    PubMed  CAS  Google Scholar 

  12. Gojo S, Kitamura S, Niwaya K, Yoshida Y, Sakaguchi H, Kawachi K (1996) Ex vivo gene transfer to transplanted heart grafts using adenoviral vector. Transplantation Proceedings 28:1818–1819

    PubMed  CAS  Google Scholar 

  13. Graham FL, Prevec L (1995) Methods for construction of adenovirus vectors. Mol Biotechnol 3:207–220

    Article  PubMed  CAS  Google Scholar 

  14. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T (1993) Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 73:1202–1207

    Article  PubMed  CAS  Google Scholar 

  15. Hajjar RJ, Schmidt U, Matsui T, Guerrero L, Lee K, Gwathmey JK, Dec G, Semigran M, Rosenzweig A (1998) Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA 95:5251–5256

    Article  PubMed  CAS  Google Scholar 

  16. Hilleman MR, Werner JH (1954) Recovery of new agents from patients with acute respiratory illness. Proc Soc Exp Biol Med 85:183–188

    PubMed  CAS  Google Scholar 

  17. Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA (1993) Quantitative determination of adenovirusmediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 90:11498–11502

    Article  PubMed  CAS  Google Scholar 

  18. Kirshenbaum LA, MacLellan WR, Mazur W, French BA, Schneider MD (1993) Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest 92:381–387

    Article  PubMed  CAS  Google Scholar 

  19. Kruijer W, van Schaik FM, Sussenbach JS (1980) Nucleotide sequence analysis of a region of adenovirus 5 DNA encoding a hitherto unidentified gene. Nucleic Acids Res 8:6033–6042

    Article  PubMed  CAS  Google Scholar 

  20. Lamping KG, Rios CD, Chun JA, Ooboshi H, Davidson BL, Heistad DD (1997) Intrapericardial administration of adenovirus for gene transfer. Am J Physiol 272:H310–H317

    PubMed  CAS  Google Scholar 

  21. Lee J, Laks H, Drinkwater DC, Blitz A, Lam L, Shiraishi Y, Chang P, Drake TA, Ardehali A (1996) Cardiac and pulmonary replacement: cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J Thorac Cardiovasc Surg 111:246–252

    Article  PubMed  CAS  Google Scholar 

  22. Marcus ML (1983) The coronary circulation in health and disease. McGraw-Hill, New York

    Google Scholar 

  23. Muhlhauser J, Jones M, Yamada I, Cirielli C, Lemarchand P, Gloe TR, Bewig B, Signoretti S, Crystal RG, Capogrossi MC (1996) Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Therapy 3:145–153

    PubMed  CAS  Google Scholar 

  24. Mullins RJ, Malias MA, Hudgens RW (1989) Isoproterenol inhibits the increase in microvascular membrane permeability produced by bradykinin. J Trauma 29:1053–1063

    Article  PubMed  CAS  Google Scholar 

  25. Nermut MV (1975) Fine structure of adenovirus Type 5: I. Virus capsid. Virology 65:480–495

    Article  PubMed  CAS  Google Scholar 

  26. Persson R, Svensson U, Everitt E (1983) Virus receptor interaction in the adenovirus system: II. Capping and cooperative binding of virions on HeLa cells. J Virol 46:956–963

    PubMed  CAS  Google Scholar 

  27. Philipson L (1967) Attachment and eclipse of adenovirus. J Virol 1:868–875

    PubMed  CAS  Google Scholar 

  28. Philipson L, Lonberg-Holm K, Pettersson U (1968) Virus-receptor interaction in an adenovirus system. J Virol 2:1064–1075

    PubMed  CAS  Google Scholar 

  29. Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84:570–573

    PubMed  CAS  Google Scholar 

  30. Shenk T (1996) Adenoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology. Lippincott-Raven, Philadelphia, pp 2111–2148

    Google Scholar 

  31. Trentin JJ, Yabe Y, Taylor G (1962) The quest for human cancer viruses. Science 137:835–849

    Article  PubMed  CAS  Google Scholar 

  32. van Ormondt H, Maat J, van Beveren CP (1980) The nucleotide sequence of the transforming early region El of adenovirus type 5 DNA. Gene 11:299–309

    Article  PubMed  Google Scholar 

  33. Weeks DL, Jones NC (1983) ElA control of gene expression is mediated by sequences 5’ to the transcriptional starts of the early viral genes. Mol Cell Biol 3:1222–1234

    PubMed  CAS  Google Scholar 

  34. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR (1993) Integrins α v β 3 and α v β 5 promote adenovirus internalization but not virus attachment. Cell 73:309–319

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Donahue, J.K. (2000). Adenovirus-mediated myocardial gene therapy. In: Hasenfuss, G., Marbán, E. (eds) Molecular Approaches to Heart Failure Therapy. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57710-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57710-9_9

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-63332-4

  • Online ISBN: 978-3-642-57710-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics